Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Hematology/Oncology Clinics of North America|September 23, 2006
Cladribine in hairy cell leukemiaRajesh Belani, Alan Saven
Case Reports in Oncological Medicine|December 18, 2012
An Association between Bevacizumab and Recurrent Posterior Reversible Encephalopathy Syndrome in a Patient Presenting with Deep Vein Thrombosis: A Case Report and Review of the LiteratureMark Lazarus, Stanley Amundson, Rajesh Belani
Leukemia & Lymphoma|October 7, 2020
Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011-2019 oncology clinic electronic health record dataMegan Braunlin, Rajesh Belani, Jacqueline Buchanan, et al.
Thrombosis Research|February 12, 2008
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patientsRachel E Tilley, Todd Holscher, Rajesh Belani, et al.
Journal of Patient-Reported Outcomes|January 18, 2021
Development and content validation of the Satisfaction and Experience Questionnaire for Granulocyte Colony-Stimulating Factor (SEQ-G-CSF)Aylin Yucel, Anne Skalicky, Olabimpe Ruth Eseyin, et al.
Blood Cancer Journal|July 2, 2020
B-cell maturation antigen expression across hematologic cancers: a systematic literature reviewAhmet Dogan, David Siegel, Nguyet Tran, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 28, 2019
A Survey of Oncologists' Perceptions and Opinions Regarding the Use of Granulocyte Colony-Stimulating FactorsAlicia Hawkins, Alysa Murphy, Michelle McNamara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 11, 2020
Patterns of granulocyte colony-stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapyPrasad L Gawade, Shuling Li, David Henry, et al.
BMC Cancer|August 11, 2019
Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational studyDerek Weycker, Robin Doroff, Ahuva Hanau, et al.
Journal of Geriatric Oncology|July 7, 2020
Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancerShuling Li, Jiannong Liu, Tingting Gong, et al.
Pageof 2